KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
Italy’s Draft WHO resolution: Improving the transparency of markets for drugs, vaccines and other health-related technologies
On February 1, 2019, the Minister of Health in Italy Dr. Giulia Grillo sent a letter to Dr. Tedros Adhanom Ghebreyesus, the Director General of the World Health Organization (WHO), with an attached “first draft” of a resolution on “Improving… Continue Reading
TRIPS Council: Statement of the European Union on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy
On 1 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/651)by South Africa to the TRIPS Council on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy. The South African paper endeavored to… Continue Reading
WTO TRIPS Council: Submission of the European Union, the United States and 9 other WTO members on Public-Private Collaborations in Innovation
On 8 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/652) by Australia; Canada; Chile; The European Union; Hong Kong, China; Japan; the Republic of Korea; Singapore; Switzerland; Chinese Taipei; and the United States to the TRIPS Council… Continue Reading
2019: KEI Comments Submitted to USTR Special 301 Review
On Thursday February 7, 2019, KEI submitted comments and intent to testify at the hearing for the 2019 US Trade Representative’s Special 301 review process. This year’s hearing will take place on Wednesday February 27, 2019 at the Office of… Continue Reading
WTO TRIPS Council: South Africa considers strict patentability criteria to address abuses in the pharmaceutical industry
On 1 February 2019, the World Trade Organization (WTO) published a submission (IP/C/W/651) by South Africa to the TRIPS Council on Intellectual Property and the Public Interest: Promoting Public Health Through Competition Law and Policy. The South African paper endeavors… Continue Reading
EB144: KEI statement on the WHO Cancer report
Knowledge Ecology International (KEI) delivered the following intervention on the WHO Cancer report (agenda item 5.7.2) on Tuesday evening, 29 January 2019. We commend the WHO secretariat for the 171-page report on “Pricing of cancer medicines and its impacts.” A… Continue Reading
EB144: KEI statement on the WHO roadmap on access to medicines, vaccines and health products
Knowledge Ecology International (KEI) delivered the following statement on the WHO roadmap on access to medicines, vaccines and health products (agenda item 5.7.1) on Tuesday evening, 29 January 2019 during the 144th session of WHO’s Executive Board. The WHO Roadmap… Continue Reading
WHO Cancer Report – Key findings
On 18 December 2018, the World Health Organization (WHO) published a “Technical report on Pricing of cancer medicines and its impacts” (hereinafter referred to as the “WHO Cancer Report”). The mandate for the WHO Cancer Report emanates from operative paragraph… Continue Reading
SCP29: General statement of Knowledge Ecology International
On Monday, 3 December 2018, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 29th Session of the Standing Committee on the Law of Patents (SCP). Thank you Chair. KEI welcomes the conclusions of SCP 28 which call upon… Continue Reading
WIPO side event, December 6, 2018, on the Implications of Article 27.3(a) of the WTO TRIPS Agreement on the patentability of gene and cell-based therapies
DATE: Thursday, 6 December 2018 TIME: 1:30 PM to 3 PM VENUE: Room B CONVENER: Knowledge Ecology International (KEI) Knowledge Ecology International (KEI) cordially invites you to attend our side event during negotiations of the 29th Session of the Standing… Continue Reading